Equipment & Buildout Checklist

Most generic startup guides list "equipment" as a single line item. For a health medical spa, equipment is 40-50% of your entire opening budget, and the mix you choose determines whether you need $80,000 or $400,000 to open the doors. A plan that doesn't itemise this looks unfinished to a lender.

The lean path is injectables-only: one treatment room, no energy-based devices, and a founder or hired injector doing Botox, dermal filler, and possibly a skin-quality treatment like PRF. The fuller path adds one or more laser or body-contouring platforms, which is where the budget swings hardest.

What actually goes on the equipment line

• Laser or energy-based device (per unit): $50,000-$200,000 - hair removal, skin resurfacing, or body contouring platforms
• Laser hair removal machine specifically: $40,000-$80,000
• IPL (intense pulsed light) device: $7,000-$30,000
• Microdermabrasion / skin-quality device: $500-$6,000
• Opening injectables inventory (Botox, Dysport, Xeomin, Daxxify, fillers): $7,000-$30,000
• Treatment room fit-out (chairs, sterilisation, medical-grade surfaces): $15,000-$50,000 per room
• EHR / practice-management + point-of-sale software: $3,000-$12,000 to set up, then a monthly subscription

Financing the equipment separately from the rest of the raise is common in this niche. Leasing lets you spread laser and device costs across 3-5 years and keeps cash free for the medical director retainer and marketing, which matter more in month one than a second laser does.

Buy once vs. buy broad

Founders who over-equip on day one usually make the same mistake: buying a platform that does five things adequately instead of one thing well. A single-application laser tuned for hair removal typically clears a room faster and needs less operator retraining than a multi-application platform marketed as doing hair, skin resurfacing, and body contouring on one chassis. The multi-application device costs more up front and, in practice, gets used for one or two of its advertised applications because staff never fully cross-train on the rest. A plan built around a single, well-utilised device against a lease payment is easier for a lender to underwrite than one built around a machine that's supposed to do everything.

Manufacturer lead times matter for your opening timeline too. Laser and body-contouring devices commonly run 6-12 weeks from order to installation once financing is approved, and most manufacturers require a certified installer and a staff training session before the device can legally be used on a patient. Build that lag into your opening date rather than into your contingency budget - a delayed laser doesn't delay your lease payment.

What It Costs to Open a Health Medical Spa

A single treatment room, injectables-only clinic can open for $50,000-$150,000. A mid-range build with one laser or body-contouring device runs $150,000-$500,000 (£118,000-£394,000). Premium multi-room clinics in expensive markets - think a two-injector, two-laser build in a major metro - can push past $1 million once build-out, staffing, and opening inventory are all in.

Where the money goes

• Build-out (medical-grade HVAC, plumbing, ADA/DDA compliance): $40,000-$150,000 (£32,000-£118,000)
• Equipment and devices: $50,000-$200,000+ per device, see the checklist above
• Medical director retainer (annualised): $18,000-$60,000/yr (£14,000-£47,000/yr)
• Opening injectables and consumables inventory: $7,000-$30,000
• Insurance (professional liability + general): $3,000-$12,000/yr
• Staff recruitment and initial payroll runway: $20,000-$76,000
• Working capital (3-6 months of overhead before break-even): $30,000-$100,000

Funding routes

In the US, an SBA 7(a) loan is the standard route - amounts up to $5 million, terms up to 25 years for real estate, and rates currently running prime plus 2.25-4.75% (roughly 8-12% as of 2025). Lenders typically want a personal credit score of 680+ and will scrutinise the medical director agreement and CPOM structure before they scrutinise the marketing plan. SBA 504 loans are the better fit if you're buying the building rather than leasing it. Equipment-specific financing is also common, since lasers and body-contouring devices double as their own collateral.

In the UK, the Start Up Loans scheme offers up to £25,000 per founder (up to £100,000 for a multi-founder team) at 6% fixed interest with free mentoring - useful for the injectables-only path, though it rarely covers a full laser build on its own. Most UK founders combine a Start Up Loan with personal capital and, once trading, asset finance for equipment. If you'd rather have someone build the lender-ready numbers with you, our business plan writers size the ask to the equipment mix you've actually chosen, not a generic template range.

Cash runway before the first profitable month

Most first-time founders underestimate how long it takes patient volume to catch up to fixed costs. Rent, the medical director retainer, insurance, and a base staffing level are all due whether you've booked five appointments or fifty that month. Budgeting six months of full operating costs as working capital - not three - is the difference between a clinic that survives a slow spring and one that runs out of cash waiting for word-of-mouth to build. Lenders reviewing an SBA or Start Up Loan application specifically look for this runway line; a plan that shows three months of buffer against an 9-18 month path to profitability reads as under-capitalised before the underwriter reaches the financials section.

Five mistakes that show up in the numbers, not the pitch

• Treating the medical director as paperwork: an engaged medical director costs more but catches protocol and liability issues that a rubber-stamp arrangement won't - and lenders can usually tell the difference from the contract terms alone
• Buying the device before proving the demand: a $150,000 laser sitting at 20% utilisation is a worse outcome than a waiting list for injectables that justifies the purchase six months later
• Discovering the ownership rule after signing a lease: Corporate Practice of Medicine requirements should shape your entity structure before you commit to premises, not after a landlord or lender asks who legally owns the clinic
• Pricing off competitor rate cards instead of true unit cost: matching a chain's advertised $15 introductory laser price without knowing your own per-unit COGS is a fast way to sell every session at a loss
• No recurring-revenue offer at launch: a clinic that only sells one-off appointments re-earns its entire monthly revenue target from zero every month, instead of starting from a membership base

Who Actually Supplies the Room

A plan that names real manufacturers reads as operator-written, not template-filled. These are the brands that actually show up on a health medical spa's opening purchase order:

• Allergan Aesthetics (AbbVie): Botox Cosmetic and Juvederm - the two products most new clinics anchor their menu around
• Galderma: Dysport and Restylane - the primary alternative injectable line, often stocked alongside Allergan for patient choice
• Merz Aesthetics: Xeomin (a "naked" neurotoxin with no accessory proteins) and Radiesse filler
• Revance: Daxxify - the longest-acting neurotoxin on the US market, priced at a premium
• Cutera, Candela, Cynosure, InMode: the four device manufacturers most commonly financed for laser hair removal, skin resurfacing, and body contouring

On the software side, practice-management platforms like Zenoti, Boulevard, and Pabau handle booking, EHR, membership billing, and inventory in one system - worth budgeting for from day one rather than bolting on later, since retrofitting membership billing into a clinic that's already trading is a real operational headache.

A vial-and-syringe-level supplier list belongs in an appendix, not the narrative section of your plan - but naming the manufacturer tier you're buying from (branded vs. compounded, where legal) tells a lender you've priced the actual product, not a category.

Branded vs. compounded, and minimum order quantities

Branded neurotoxin and filler come with volume-based rebate programmes - most manufacturers offer tiered pricing once a clinic hits a monthly vial or syringe threshold, which is worth modelling into your margin forecast for year two rather than year one, since new clinics rarely hit the top rebate tier out of the gate. Compounded alternatives exist in some product categories and are meaningfully cheaper, but carry more regulatory scrutiny and liability exposure; most medical directors will only sign off on branded product for a first-year clinic specifically to keep the malpractice and CPOM conversation simple. Distributor relationships also matter more than founders expect - a sales rep who visits monthly and flags new product launches early is worth more to a single-location clinic than a marginally better unit price from a rep who never shows up.

Medical Director & Licensing Rules

This is the section where most health medical spa plans fall apart, because the ownership question isn't optional. In virtually every US state, any clinic performing neurotoxin injections, dermal fillers, laser treatments, chemical peels, or prescription-based services must operate under an actively engaged, licensed physician serving as medical director - not a name on a contract who never sets foot in the building.

United States

• Medical director agreement: a physician overseeing clinical protocols, typically $1,500-$5,000/month
• Corporate Practice of Medicine (CPOM) compliance: varies sharply by state - see below
• State business licence + medical facility registration
• Individual practitioner licences for every RN, NP, PA, or aesthetician on staff
• DEA registration if the clinic prescribes or stocks controlled substances
• OSHA compliance documentation for sharps, sterilisation, and bloodborne pathogens

CPOM enforcement is the detail that catches first-time founders. California requires a physician or physician-owned professional corporation to hold at least 51% of the entity. Florida allows a non-physician to own the business as long as they don't control clinical decisions, with a board-certified physician - often dermatology or plastic surgery - as medical director. Alabama doesn't enforce CPOM at all, so a non-physician can own the spa outright provided a licensed physician is named as medical director. Your plan's ownership structure section should name your state's rule explicitly, because a lender or investor who's financed a med spa before will ask.

United Kingdom

UK regulation is mid-transition. As of mid-2026, the Care Quality Commission (CQC) regulates only higher-risk procedures - genital and intimate-area filler augmentation - while standard facial Botox and dermal filler remain outside CQC's regulated-activity scope. A new risk-based framework has been consulted on that would categorise treatments as Red, Amber, or Green: Botox and fillers sit in the Amber category, meaning a non-medical practitioner can administer them only under the supervision of a named, regulated prescriber (a doctor or prescribing nurse). Since 1 June 2025, Botox prescribing must involve a face-to-face consultation with the prescriber - remote-only prescribing is no longer compliant. Local authority licensing for Botox and filler businesses is expected to follow once the enabling legislation passes; a plan written today should assume licensing tightens, not loosens, over the next two years.

Two more state examples worth planning around: Texas enforces CPOM strictly, requiring the medical practice itself to be physician-owned even though a management services organisation can legally handle the non-clinical business side under a management agreement. New York similarly restricts ownership of the professional medical entity to licensed physicians, which is why most non-physician-led med spas there operate under an MSO structure - two linked entities, one clinical and physician-owned, one for business operations - rather than a single company. If your state falls into this category, your business plan's legal structure section needs to describe both entities, not just the trading name on the door.

Other jurisdictions

In Australia, cosmetic injectables are classified as prescription-only medicines under AHPRA. Only registered health practitioners - doctors, nurse practitioners, or registered nurses acting under a doctor's authority - may administer or supervise treatment, with mandatory qualification and continuing professional development requirements tightened after the 2023 cosmetic surgery reforms. In Canada, oversight sits with the provincial college of physicians and surgeons rather than a single federal body, so a clinic in Ontario and a clinic in British Columbia can face materially different supervision and delegation rules for the same treatment menu - another reason a generic, non-jurisdiction-specific plan tends to fall apart the moment a real lender or regulator reads it closely.

How the Money Actually Works

Botox and dermal fillers typically anchor 40-60% of revenue in a new health medical spa, with laser and body-contouring services, memberships, and skincare retail filling the rest. Cost of goods (product, disposables) should run 15-35% of revenue, and labour shouldn't exceed roughly 35% as the clinic scales past its first injector.

A worked example

A single-location clinic with two treatment rooms and one full-time injector reaches roughly $150,000 in monthly revenue by month 18 - about $1.8 million annualised. Against 25% COGS (injectables and disposables), 32% labour (injector, aesthetician, front desk), 8% marketing, 10% rent and utilities, and a 5% medical director retainer, the clinic nets close to 20% margin - roughly $360,000 a year before owner's draw and tax.

At the treatment level: a typical Botox appointment uses about 35 units. At $12-$15 per unit, that's $420-$525 in revenue against roughly $175 in product cost (based on a $500 wholesale price per 100-unit vial) - a gross margin near 55-60% before labour is applied. Dermal filler syringes retail at $600-$900 against a $200-$400 wholesale cost, a similar margin band.

Industry-wide, the average single-location US med spa now generates $1.9M-$2M in annual revenue at maturity, with net margins of 20-25% and top performers reaching 30-40%. Most clinics run below break-even for the first 9-18 months while client volume and membership numbers build, then cross into profitability by year two. Recurring revenue - monthly membership tiers that bundle a set number of units or treatments - is the single biggest lever for smoothing that early cash-flow gap, because it converts a walk-in business into one with predictable monthly billing.

What a membership tier actually adds

A typical membership structure charges $150-$300 a month for a bundled allotment of units, a skincare product credit, and a discount on additional treatments. At 80 active members and an average $200/month tier, that's $16,000 in guaranteed monthly revenue before a single walk-in books an appointment - roughly 11% of the $150,000 monthly target in the worked example above, arriving with none of the marketing spend a one-off appointment requires. Membership revenue also compounds: a member is statistically more likely to add a filler or laser appointment on top of their monthly credit than a first-time walk-in is to return within 90 days, which is why chains like Milan Laser and SEV Laser build their pricing around package and membership commitments rather than single-visit pricing.

Marketing spend should track the growth stage, not stay fixed. Established, profitable med spas typically allocate 5-10% of gross revenue to marketing once the client base is stable. Startups in their first 12 months usually need to run closer to 15-20% of projected revenue, front-loaded into the first two quarters, to build the initial booking volume a new medical director and landlord both want to see before they consider the clinic "proven."

A second worked example, once a laser device is added to the injectables-only model above: the same clinic adds one energy-based device in month 14, financed on a $2,400/month equipment lease. At a conservative 15 hair-removal or resurfacing sessions a week averaging $250/session, that's an additional $9,750 a month in gross revenue against roughly $3,200 in labour and consumables and the $2,400 lease payment - net contribution of about $4,150 a month once the device is running at that utilisation. Below that utilisation threshold, the device is a drag on margin rather than a lift, which is exactly why the injectables-first sequencing matters: it lets the clinic prove it can fill 15 weekly device slots before the lease payment starts.

The Health Medical Spa Market in 2026

The global medical spa market was valued at approximately $25.3 billion in 2025, according to Precedence Research, which projects the market toward $97.9 billion by 2035. Separately, Technavio forecasts the market adding $46.1 billion between 2026 and 2030 at a 23% CAGR - growth driven by rising acceptance of minimally invasive procedures and expanding wellness-tourism demand.

In the US, there are roughly 10,488 med spa locations according to Orbital's location-level analysis, and the American Med Spa Association puts average single-location revenue at $1.9M-$2M annually. Facial treatments hold the largest revenue share of any procedure category, and the adult segment (rather than younger patients) accounts for roughly 70% of treatment volume.

The UK market is smaller but growing faster in percentage terms: an estimated £3.2-£3.6 billion in 2025-2026, forecast to reach £5.1 billion by 2028 according to PolicyBee, an annual growth rate above 10%. Injectables alone make up roughly 65% of total UK aesthetics revenue, and over 7.7 million people in the UK received an aesthetic treatment in the most recent reporting year.

What patients are actually booking

Facial treatments hold the largest single revenue share of any category, at roughly 53.6% of total medical spa spend, ahead of body contouring, laser hair removal, and skin-quality treatments combined. The adult segment - broadly 25 to 55 - accounts for around 70.8% of treatment volume, not the younger demographic many first-time founders assume they're building for. That matters for a business plan's marketing section: a clinic pitched at a 22-year-old Instagram audience is targeting a smaller slice of actual spend than one built around a 35-50-year-old client with more disposable income and a longer average relationship with the clinic. Female patients still lead the market by volume, but the male segment is the fastest-growing demographic across most reporting regions, which is worth a line in the customer-segment section of a plan built for 2026 rather than 2020.

Who you're actually competing with

Scale matters more in this niche than most founders expect walking in. Milan Laser passed 400 clinics by August 2025 by specialising almost entirely in laser hair removal - proof that a narrow menu can scale faster than a full-service one. LaserAway, backed by more than $70 million from Ares Management, has been opening a new location roughly every ten days while diversifying from hair and tattoo removal into full aesthetic dermatology. Ideal Image runs around 175 US locations and SEV Laser more than doubled its footprint to over 50 locations by late 2025 on an accessible-pricing model, with treatments starting near $15. None of these chains compete on being the cheapest full-service option - they win by being unmistakably the best at one thing. A single-location plan should pick its own version of that focus rather than trying to match a chain's menu breadth on a fraction of its capital.

For a plan built around a narrower medical-aesthetic specialty rather than a full-menu spa, our Botox clinic business plan template and aesthetic clinic business plan template cover the injectables-first and full-aesthetic-clinic models in more depth.

Questions Founders Keep Asking

How long does it take to get a medical spa licensed and open?

Budget 4-8 months in the US once you count medical director recruitment, state licensing, build-out permitting, and equipment lead times - laser and body-contouring devices can have 6-12 week manufacturer lead times on their own. In the UK, the current absence of a mandatory Botox/filler licence shortens this, but that's expected to change once the local-authority licensing scheme comes into force, so plan for a similar timeline regardless.

What insurance does a health medical spa need?

Professional liability (malpractice) cover for every clinical staff member, general liability for the premises, and - in the US - often a separate cyber/data policy given how much patient health information a practice-management system holds. Annual premiums for a small clinic typically run $3,000-$12,000 combined, scaling with procedure mix and injector headcount.

Should a first clinic be injectables-only or include a laser device?

Most successful single-location launches start injectables-only, prove demand and pricing power over 6-12 months, then finance a first device once cash flow supports the lease payment. Buying a $150,000 laser before the injectables side is profitable is one of the more common ways first-time founders overextend a startup budget.

Can I open a health medical spa as a side business while employed elsewhere?

Legally, yes in most jurisdictions, but practically it's difficult - the medical director relationship, clinical scheduling, and compliance documentation all require someone actively managing the business day to day. Most lenders and medical directors will also expect the named owner-operator to be present, not absentee, particularly in strict CPOM states.

How many staff does a first-location clinic actually need?

A single-treatment-room launch typically runs on three roles: one injector (often the founder), one front-desk/patient-coordinator hire handling scheduling and membership billing, and a part-time or contracted aesthetician for skincare and non-injectable treatments. A second injector is usually the first hire once weekly booking consistently exceeds what one clinician can deliver - adding staff ahead of that demand signal is one of the faster ways to erode the 32% labour-cost target modelled in the revenue section above.

Do I need a separate business plan for an equipment loan versus the initial launch?

Not necessarily a separate plan, but equipment lenders and lease providers typically want to see utilisation projections specific to that device - expected weekly sessions, average ticket, and the break-even utilisation rate - rather than the whole-clinic financials alone. Structuring your plan with a clear per-device economics section, as in the worked example above, means the same document can support both the opening raise and a device-specific lease application 12-18 months later without a rewrite.

Inside a Real Health Medical Spa Business Plan

Here's an extract from the kind of plan our team writes - structured for a lender or medical director to read in one sitting:

What's in the Template

Every Avvale business plan template includes these sections, pre-structured for your industry:

• Executive Summary - Your clinic at a glance, written to hook a lender or medical director in 60 seconds, covering the treatment menu, funding ask, and headline financial targets
• Company & Ownership Overview - Legal structure, medical director agreement, and a CPOM-compliant ownership split written for your specific state or jurisdiction, not a generic placeholder
• Industry Analysis - Market size, growth trends, and the specific regulatory shifts affecting your jurisdiction, including licensing changes expected during your first two years of trading
• Customer Analysis - Treatment-level demand, price sensitivity, demographic breakdown, and repeat-visit patterns by service line
• Competitor Analysis - Local independents, national chain competitors, and a clear statement of where a single-location clinic can actually win against both
• Marketing Plan - Channels, membership structure, launch-phase spend versus steady-state spend, and patient-acquisition cost targets by treatment category
• Operations Plan - Room scheduling, staffing structure, supplier relationships, and clinical-governance workflows that satisfy both a lender and a medical director reviewing the same document
• Management Team - Founder and medical director bios, plus any advisory clinicians, with credentials framed the way an underwriter reads them

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and an equipment-financing schedule sized to your specific device mix rather than a sector-wide average. It's built to stand up to the same scrutiny an SBA 7(a) underwriter or a Start Up Loans Company assessor would apply, since that's who most founders using this template are ultimately trying to convince.

Frequently Asked Questions